Laman UtamaNATCOPHARM • NSE
add
Natco Pharma Ltd.
Tutup sebelumnya
₹1,374.75
Julat hari
₹1,353.05 - ₹1,386.40
Julat tahun
₹752.45 - ₹1,639.00
Permodalan pasaran
242.96B INR
Bilangan Purata
534.22K
Nisbah P/E
12.49
Hasil dividen
0.42%
Pertukaran utama
NSE
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 13.71B | 32.94% |
Perbelanjaan pengendalian | 4.35B | 8.42% |
Pendapatan bersih | 6.77B | 83.55% |
Margin untung bersih | 49.40 | 38.07% |
Pendapatan bagi setiap syer | 37.81 | 83.54% |
EBITDA | 8.03B | 75.44% |
Kadar cukai berkesan | 17.32% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 24.63B | 102.65% |
Jumlah aset | 82.45B | 31.83% |
Jumlah liabiliti | 10.88B | 13.26% |
Jumlah ekuiti | 71.57B | — |
Syer tertunggak | 179.13J | — |
Harga kepada buku | 3.44 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 27.91% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 6.77B | 83.55% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US. Wikipedia
Diasaskan
1981
Ibu pejabat
Tapak web
Pekerja
4,016
